Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|1|1|1-16

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.1, 2002-02, pp. : 1-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Methyl-D-Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 749-770

Bentham Science Publishers

Access to resources Recommend Favorite

Potential and Current Use of N -Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of Aging

By Le D.A.  

Drugs & Aging, Vol. 18, Iss. 10, 2001-10 ,pp. : 717-724

Adis International

Access to resources Recommend Favorite

The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-01 ,pp. : 16-25

Bentham Science Publishers

Access to resources Recommend Favorite

A novel NMDA receptor antagonist protects against N-methyl-d-aspartate- and glutamate-induced neurotoxicity in the goldfish retina

By Tyan S.-H.   Sue T.-Y.   Hon Y.-S.   Gean P.-W.   Chang Y.-C.  

European Journal of Pharmacology, Vol. 321, Iss. 2, 1997-02 ,pp. : 171-179

Elsevier

Access to resources Recommend Favorite

Novel N-methyl-d-aspartate receptor antagonists: a review of compounds patented since 2006

By Koller Manuel   Urwyler Stephan  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1683-1702

Informa Healthcare

Access to resources Recommend Favorite